Literature DB >> 11587919

Role of nitric oxide in the control of ocular blood flow.

L Schmetterer1, K Polak.   

Abstract

In the recent years it has been recognized that nitric oxide is an important regulator of ocular blood flow. Nitric oxide is involved in the control of basal blood flow in the choroid, optic nerve and the retina. In addition, nitric oxide mediates a number of vasodilator responses in ocular vessels to agonists such as acetylcholine, bradykinin, histamine, substance P and insulin. Nitric oxide also plays a role in hypercapnia-induced vasodilation in the choroid and is a modulator of pressure autoregulation in this vascular bed. Abnormalities of the L-arginine/nitric oxide system have been observed in a variety of ocular diseases including glaucoma, diabetic retinopathy and retinopathy of prematurity. This makes the L-arginine/nitric oxide pathway an attractive target for therapeutic interventions. Additional research is required, particularly in characterizing the role of the three nitric oxide synthase isoforms in the control of ocular perfusion, to implement this concept into the clinical management of ocular diseases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11587919     DOI: 10.1016/s1350-9462(01)00014-3

Source DB:  PubMed          Journal:  Prog Retin Eye Res        ISSN: 1350-9462            Impact factor:   21.198


  50 in total

1.  Light responses and morphology of bNOS-immunoreactive neurons in the mouse retina.

Authors:  Ji-Jie Pang; Fan Gao; Samuel M Wu
Journal:  J Comp Neurol       Date:  2010-07-01       Impact factor: 3.215

2.  Cyclic GMP, sodium nitroprusside and sodium azide reduce aqueous humour formation in the isolated arterially perfused pig eye.

Authors:  Mohammad Shahidullah; Maurice Yap; Chi-Ho To
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

3.  The role of lipid dysregulation and vascular risk factors in glaucomatous retrobulbar circulation.

Authors:  Monika Modrzejewska; Wilhelm Grzesiak; Daniel Zaborski; Anna Modrzejewska
Journal:  Bosn J Basic Med Sci       Date:  2015-03-15       Impact factor: 3.363

Review 4.  Hypertensive retinopathy revisited: some answers, more questions.

Authors:  A Grosso; F Veglio; M Porta; F M Grignolo; T Y Wong
Journal:  Br J Ophthalmol       Date:  2005-12       Impact factor: 4.638

5.  Light modulation, not choroidal vasomotor action, is a regulator of refractive compensation to signed optical blur.

Authors:  Melanie J Murphy; David P Crewther; Melinda J Goodyear; Sheila G Crewther
Journal:  Br J Pharmacol       Date:  2011-11       Impact factor: 8.739

6.  Vascular tone pathway polymorphisms in relation to primary open-angle glaucoma.

Authors:  J H Kang; S J Loomis; B L Yaspan; J C Bailey; R N Weinreb; R K Lee; P R Lichter; D L Budenz; Y Liu; T Realini; D Gaasterland; T Gaasterland; D S Friedman; C A McCarty; S E Moroi; L Olson; J S Schuman; K Singh; D Vollrath; G Wollstein; D J Zack; M Brilliant; A J Sit; W G Christen; J Fingert; J P Forman; E S Buys; P Kraft; K Zhang; R R Allingham; M A Pericak-Vance; J E Richards; M A Hauser; J L Haines; J L Wiggs; L R Pasquale
Journal:  Eye (Lond)       Date:  2014-03-07       Impact factor: 3.775

Review 7.  Pharmacotherapy of glaucoma.

Authors:  Doreen Schmidl; Leopold Schmetterer; Gerhard Garhöfer; Alina Popa-Cherecheanu
Journal:  J Ocul Pharmacol Ther       Date:  2015-01-14       Impact factor: 2.671

8.  Lack of effect of nitroglycerin on the diameter response of larger retinal arterioles in normal persons during hypoxia.

Authors:  Musa Yasin Kaya; Line Petersen; Toke Bek
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-11-30       Impact factor: 3.117

9.  Intraocular pressure and aqueous humor flow during a euglycemic-hyperinsulinemic clamp in patients with type 1 diabetes and microvascular complications.

Authors:  James T Lane; Luann Larson; Shan Fan; Julie A Stoner; Eyal Margalit; Carol B Toris
Journal:  BMC Ophthalmol       Date:  2010-06-23       Impact factor: 2.209

10.  Candesartan attenuates diabetic retinal vascular pathology by restoring glyoxalase-I function.

Authors:  Antonia G Miller; Genevieve Tan; Katrina J Binger; Raelene J Pickering; Merlin C Thomas; Ram H Nagaraj; Mark E Cooper; Jennifer L Wilkinson-Berka
Journal:  Diabetes       Date:  2010-09-17       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.